Xeris Biopharma Holdings (XERS) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Xeris Biopharma Holdings | 1.37 Bn | 1.25 Bn | 79.59 Mn | 173.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 173.59 Mn |
| Mar 31, 2026 | 172.56 Mn |
| Dec 31, 2025 | 166.22 Mn |
| Sep 30, 2025 | 165.53 Mn |
| Jun 30, 2025 | 161.22 Mn |
| Mar 31, 2025 | 156.01 Mn |
| Dec 31, 2024 | 149.43 Mn |
| Sep 30, 2024 | 149.00 Mn |
| Jun 30, 2024 | 148.94 Mn |
| Mar 31, 2024 | 148.22 Mn |
| Dec 31, 2023 | 138.13 Mn |
| Sep 30, 2023 | 138.07 Mn |
| Jun 30, 2023 | 138.01 Mn |
| Mar 31, 2023 | 137.29 Mn |
| Dec 31, 2022 | 136.27 Mn |
| Sep 30, 2022 | 135.96 Mn |
| Jun 30, 2022 | 135.96 Mn |
| Mar 31, 2022 | 135.53 Mn |
| Dec 31, 2021 | 79.03 Mn |
| Sep 30, 2021 | 66.50 Mn |